Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Allergy Immunotherapies market was valued at 2595 Million US$ in 2018 and is projected to reach 5915 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 10.85% during the forecast period.
This report presents the market size and development trends by detailing the Allergy Immunotherapies market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Allergy Immunotherapies market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Allergy Immunotherapies industry and will help you to build a panoramic view of the industrial development.
Allergy Immunotherapies Market, By Type:
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Allergy Immunotherapies Market, By Application:
Allergic Rhinitis
Allergic Asthma
Other
Some of the leading players are as follows:
Sementis
DBV Technologies
Torii
HAL Allergy
Genentech
Circassia
Shionogi
Tunitas Therapeutics
Adamis Pharmaceuticals
Laboratorios LETI
ASIT biotech
Anergis
Mitsubishi Tanabe Pharma
Biomay
Nycomed
VentiRx Pharmaceuticals
Aimmune Therapeutics
Verona Pharma
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Allergy Immunotherapies Market: Technology Type Analysis
-
4.1 Allergy Immunotherapies Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Allergy Immunotherapies Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Subcutaneous Immunotherapy
4.3.2 Sublingual Immunotherapy
5 Allergy Immunotherapies Market: Product Analysis
-
5.1 Allergy Immunotherapies Product Market Share Analysis, 2018 & 2026
-
5.2 Allergy Immunotherapies Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Allergy Immunotherapies Market: Application Analysis
-
6.1 Allergy Immunotherapies Application Market Share Analysis, 2018 & 2026
-
6.2 Allergy Immunotherapies Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Allergic Rhinitis
6.3.2 Allergic Asthma
6.3.3 Other
7 Allergy Immunotherapies Market: Regional Analysis
-
7.1 Allergy Immunotherapies Regional Market Share Analysis, 2018 & 2026
-
7.2 Allergy Immunotherapies Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Sementis
9.1.1 Sementis Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 DBV Technologies
9.2.1 DBV Technologies Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Torii
9.3.1 Torii Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 HAL Allergy
9.4.1 HAL Allergy Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Genentech
9.5.1 Genentech Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Circassia
9.6.1 Circassia Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Shionogi
9.7.1 Shionogi Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Tunitas Therapeutics
9.8.1 Tunitas Therapeutics Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Adamis Pharmaceuticals
9.9.1 Adamis Pharmaceuticals Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Laboratorios LETI
9.10.1 Laboratorios LETI Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 ASIT biotech
9.11.1 ASIT biotech Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Anergis
9.12.1 Anergis Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Mitsubishi Tanabe Pharma
9.13.1 Mitsubishi Tanabe Pharma Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Biomay
9.14.1 Biomay Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 Nycomed
9.15.1 Nycomed Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 VentiRx Pharmaceuticals
9.16.1 VentiRx Pharmaceuticals Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
9.17 Aimmune Therapeutics
9.17.1 Aimmune Therapeutics Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.17.5 SWOT analysis
9.18 Verona Pharma
9.18.1 Verona Pharma Company overview
9.18.2 Financial performance
9.18.3 Product benchmarking
9.18.4 Strategic initiatives
9.18.5 SWOT analysis
The List of Tables and Figures (Totals 102 Figures and 136 Tables)
Figure Subcutaneous Immunotherapy Allergy Immunotherapies market, 2015 - 2026 (USD Million)
Figure Sublingual Immunotherapy Allergy Immunotherapies market, 2015 - 2026 (USD Million)
Figure Allergic Rhinitis market, 2015 - 2026 (USD Million)
Figure Allergic Asthma market, 2015 - 2026 (USD Million)
Figure Other market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Allergy Immunotherapies market, by country, 2015 - 2026 (USD Million)
-
Table North America Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table North America Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table North America Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table Canada Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table Canada Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table Europe Allergy Immunotherapies market, by country, 2015 - 2026 (USD Million)
-
Table Europe Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table Europe Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table Europe Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table Germany Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table Germany Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table France Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table France Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table Italy Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table Italy Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table Spain Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table Spain Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Allergy Immunotherapies market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table China Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table China Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table Japan Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table Japan Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table India Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table India Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Allergy Immunotherapies market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table MEA Allergy Immunotherapies market, by country, 2015 - 2026 (USD Million)
-
Table MEA Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table MEA Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table MEA Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Allergy Immunotherapies market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Allergy Immunotherapies market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Allergy Immunotherapies market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Sementis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table DBV Technologies Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Torii Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table HAL Allergy Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Genentech Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Circassia Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Shionogi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Tunitas Therapeutics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Adamis Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Laboratorios LETI Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table ASIT biotech Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Anergis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mitsubishi Tanabe Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biomay Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Nycomed Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table VentiRx Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Aimmune Therapeutics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Verona Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
